In this March 16, 2020 file photo, Kaiser Permanente Washington Health Research shows subjects in a Phase 1 safety trial clinical trial of a potential vaccine...
modernOn Wednesday, after a biotech company released promising data on a potential clinical trial of the coronavirus vaccine, the company’s stock price soared 12 percent on...
[The stream is slated to start at 10:00 a.m. ET. Please refresh the page if you do not see a player above at that time.]
Recent Comments